A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Abstract
The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases prostate cancer (PCa) mortality.To determine whether PSA screening decreases PCa mortality for up to 16yr and to assess results following adjustment for nonparticipation and the number of screening rounds attended.This multicentre population-based randomised screening trial was conducted in...
Paper Details
Title
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Published Date
Jul 1, 2019
Journal
Volume
76
Issue
1
Pages
43 - 51
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History